Skip to main content
OpenTrials
Completed

NCT Number: NCT03858101

SNAP: Study Nutrients in Adult PKU

Phenylketonuria (PKU) is a rare inherited metabolic disorder, where subjects are born with a genetic deficiency in the phenylalanine hydroxylase enzyme (PAH), which leaves them unable to convert Phenylalanine (Phe) into Tyrosine (Tyr). PKU patients have specific dietary needs and must follow a restrictive diet in the aim of preventing toxic levels of the amino acid phenylalanine (Phe) accumulation.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The aim of this explorative cross-sectional study is to gain quantitative insights on blood nutrient levels of adult PKU patients on a protein substitute.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

  • Inclusion Criteria:

Both PKU and Non-PKU comparison subjects:

  • Age ≥18 years
  • Willing and able to provide signed informed consent PKU specific inclusion criteria
  • PKU patients identified by newborn screening and started low Phe diet before 1 month age
  • Usage of at least one Phe-free protein substitute (i.e. an amino acid mixture including micronutrients) on a daily basis for at least 26 consecutive weeks up to Visit 1

Non-PKU comparison subjects specific inclusion criteria:

  • Same age- (±3 years) and sex as an included PKU subject
  • Exclusion Criteria:

Both PKU and Non-PKU comparison subjects:

  • For women: Currently pregnant or lactating
  • Current psychiatric disorders
  • Current Substance Use Disorders (as described in DSM V)
  • Current use of psychotropic and/or inotropic medication
  • Omega-3, antioxidant, (multi)vitamin and/or (multi)mineral supplement use within six weeks prior to entry in the study
  • Severe hepatic, thyroid or renal dysfunction
  • No acute illnesses like flu, diarrhea, or vomiting (subjects should be symptom free for a week prior to V1)
  • Participation in any other clinical intervention studies involving test products concomitantly or within six weeks prior to entry into the study
  • Other family members taking part in this study

PKU subject specific exclusion criteria:

  • Use of BH4, or drugs that may interfere with main outcomes

Non-PKU comparison subjects specific exclusion criteria:

  • Any condition or special diet (e.g. vegan or vegetarian diet) that effects the metabolism and/or normal dietary pattern/intake
  • A first or second degree relative with inborn errors of metabolism
  • Living together with someone with inborn errors of metabolism (e.g. partner, spouse or roommate)

Treatment and study plan

Primary outcomes

  1. Blood nutritional status

    Time frame: day 1

    Micro-and macronutrients and amino acid levels [in a.o. mg/L]

Secondary outcomes

  1. Blood nutritional status

    Time frame: day 1

    Phe/Tyr ratio [µmol/L]

  2. Nutrient intake

    Time frame: day 1 - day 7

    measured by three-day food diary. Nutrients in [mg/day]

  3. Subjective cognitive well-being

    Time frame: day 1 - day 7

    measured by FACT-Cog questionnaire: [four domains [score-range): 1) patients' perceived cognitive impairments [0-80]; 2) perceived cognitive abilities [0-36]; 3) noticeability or comments from others [0-16]; 4) impact of cognitive changes on quality of life [0-16]. A summary score is obtained by summing all item scores [0-148].

Sponsors and collaborators

Lead sponsor

Nutricia Research

Industry

Registry information

Official study title

An Exploratory Matched Case-control Study to Measure Blood Nutrient Levels of Adult PKU Patients on a Protein Substitute.

Acronym: SNAP

Important dates

Study start
2019
Primary completion
2023
Study completion
2023
First posted
Feb 28, 2019
Registry last updated
Jun 2, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.